Results for tag: "Urinary Tract Cancer Drug"

The Urinary Tract Cancer Drug market is focused on the treatment of bladder cancer. Bladder cancer is the fourth most common cancer in the United States, and is the most common type of urinary tract cancer. Treatment options for bladder cancer include chemotherapy, radiation therapy, and surgery. Drugs used to treat bladder cancer include monoclonal antibodies, small molecule inhibitors, and immunotherapies. These drugs target specific pathways involved in the growth and spread of bladder cancer cells. The Urinary Tract Cancer Drug market is highly competitive, with many companies developing and marketing drugs for bladder cancer. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, and Roche. Show Less Read more